ReviewThe Permanente journal2025
Proteinuria Screening in the Primary Care Office: A Review and a Quality Improvement Project.
Review in The Permanente journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProteinuria is associated with substantial cardiovascular and renal morbidity, mortality, and increased rates of hospitalization. It serves as an early indicator of chronic kidney disease (CKD).
objectivesThis review examined the relationship between proteinuria, CKD, and major adverse cardiovascular events, summarized evidence-based therapies, identified gaps in screening, and presented a quality improvement (QI) project from Kaiser Permanente East Bay.
methodsThe authors conducted a literature review and a QI project using the Kaiser Permanente national CKD staging algorithm. Patients aged 18-75 years old with CKD stages 3 or 4 were identified and categorized by comorbidities. Screening rates were analyzed.
resultsAll patients with diabetes and CKD 3 and 4 received proteinuria screening. Screening rates were lower among patients with hypertension and without diabetes.
conclusionsEarly detection and intervention can reduce major adverse cardiovascular events and CKD progression. The QI project highlights effective workflows and the need to expand screening protocols to broader populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.